Furthermore, these mice would provide an excellent model to test
novel therapies aimed at preventing metastasis.
Not exact matches
PIND's goal is an integrated, interdisciplinary approach to the study of neurodegenerative diseases and their mechanisms, with the
aim of transforming cutting - edge science into
novel therapies and diagnostics that directly benefit individuals affected by neurodegenerative diseases.
Based on these surprising therapeutic effects, the scientists initiated experiments
aimed at unraveling the underlying molecular mechanisms of the
novel combination
therapy.
His key investments in regenerative medicine technologies have laid the groundwork for
novel approaches to treatments
aimed at generating not merely palliative but actual curative and restorative
therapies.
In line with the objectives of the International Rare Disease Research Consortium (IRDiRC), we
aim to develop
novel tools that will allow to make more accurate diagnoses, predict the disease course and the efficacy of available treatments, and help developing new and better
therapies for rare kidney diseases.
To build upon the encouraging early discoveries, Helmsley renewed and expanded its Crohn's funding for the Institute in 2013 to begin new work with three major
aims: 1) continue studies of individual genes to determine how genetic differences between Crohn's patients and healthy individuals contribute to the disease; 2) evaluate promising small molecules in disease - relevant studies and prioritize insights from genetics to help develop
novel therapeutics; and 3) begin basic experimentation in animal models with Crohn's disease to provide the data necessary to begin testing new
therapies in humans.
The initiative
aims to strengthen collaborations between SBP scientists, expand the range of scientific expertise and research capabilities and foster research alliances with industry partners working in neuroscience and drug discovery research with the ultimate goal of translating
novel ideas and discoveries into
therapies that improve the life of patients suffering from brain diseases.
October 1, 2015 University of Chicago researchers awarded $ 3.5 million as part of national consortium to transform diagnosis and treatment of psychotic disorders The National Institute of Mental Health (NIMH) has awarded researchers from the University of Chicago $ 3.5 million as part of the second phase of the Bipolar - Schizophrenia Network on Intermediate Phenotypes (B - SNIP2)-- a multi-university consortium that
aims to establish a new system of diagnosis for psychotic diseases based on biomarkers, and guide the development of
novel therapies.